81047-99-6CC(C)(C)NCC(O)COc1cccc2[nH]c(=O)[nH]c12UMQUQWCJKFOUGV-UHFFFAOYSA-NCGP 12177 is a benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group. It has a role as a beta-adrenergic antagonist. It is a member of benzimidazoles, an aromatic ether, a secondary alcohol and a secondary amino compound.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Drugs that selectively bind to and activate beta-adrenergic receptors.
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
UsesCGP 12177 Hydrochloride is a selective β3-adrenoceptor agonist.
No reaction records under the current filter.
Loading…
81047-99-6DTXSID901001733CHEMBL420746CHEBI:73288DefinitionChEBI: A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.